Compare Nova Leap Health Corp. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 24 Million (Micro Cap)
24.00
NA
0.00%
0.05
4.96%
0.92
Revenue and Profits:
Net Sales:
11 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
17.65%
0%
17.65%
6 Months
25.0%
0%
25.0%
1 Year
-13.04%
0%
-13.04%
2 Years
50.0%
0%
50.0%
3 Years
-23.08%
0%
-23.08%
4 Years
-64.29%
0%
-64.29%
5 Years
-18.92%
0%
-18.92%
Nova Leap Health Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.04%
EBIT Growth (5y)
21.98%
EBIT to Interest (avg)
-0.31
Debt to EBITDA (avg)
0.94
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
1.35
Tax Ratio
29.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.68%
ROE (avg)
2.19%
Valuation key factors
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
0.96
EV to EBIT
22.05
EV to EBITDA
12.09
EV to Capital Employed
0.96
EV to Sales
0.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.36%
ROE (Latest)
2.12%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
11.10
10.20
8.82%
Operating Profit (PBDIT) excl Other Income
0.80
0.40
100.00%
Interest
0.10
0.10
Exceptional Items
-0.00
-0.10
100.00%
Consolidate Net Profit
-0.70
-0.10
-600.00%
Operating Profit Margin (Excl OI)
43.70%
10.60%
3.31%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 8.82% vs 10.87% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -600.00% vs -108.33% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
35.30
35.30
Operating Profit (PBDIT) excl Other Income
2.00
1.80
11.11%
Interest
0.10
0.20
-50.00%
Exceptional Items
-0.30
-1.70
82.35%
Consolidate Net Profit
1.90
-1.40
235.71%
Operating Profit Margin (Excl OI)
33.50%
17.60%
1.59%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 0.00% vs -3.81% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 235.71% vs -27.27% in Dec 2023
About Nova Leap Health Corp. 
Nova Leap Health Corp.
Pharmaceuticals & Biotechnology
Nova Leap Health Corp is a Canada-based home health care services company. The Company provides personal home care and support services. It operates in four states: Vermont, New Hampshire, Massachusetts, and Rhode Island as well as Nova Scotia, Canada. It provides clients with on-going assistance with activities of daily living (ADL), which includes bathing, dressing, grooming, meal preparation, housekeeping, errands, transportation and medication reminders. Its care centers include Armistead Home Care, All About Home Care, Family Tree Home Care, Home Health Solutions, Always Home and Comprehensive Home Care.
Company Coordinates 
Company Details
5003-7071 Bayers Rd , HALIFAX NS : B3L 2C2
Registrar Details






